Eterna Therapeutics Inc.Separation Agreement • May 5th, 2023 • Eterna Therapeutics Inc. • Pharmaceutical preparations • California
The purpose of this separation agreement (the “Separation Agreement”) is to memorialize the terms and conditions of your voluntary resignation from employment with Eterna Therapeutics Inc. (the “Company”) and its subsidiaries and affiliates (together with the Company collectively, the “Company Group”), as well as the termination of that certain Amended and Restated Executive Employment Agreement, dated May 10, 2022, by and between YOU (the terms “YOU” and “YOUR” refer to Andrew Jackson) and the Company (for clarity, as referenced in the Employment Agreement, the Company is formerly known as Brooklyn ImmunoTherapeutics, Inc.) (the “Employment Agreement”). The Company accepts YOUR voluntary resignation and agrees to report your resignation as a voluntary resignation on the applicable Form 8-K. Capitalized terms used but not defined herein shall have the respective meanings ascribed thereto in the Employment Agreement.
